References
- Chipps BE, Szefler SJ, Simons FE, Haselkorn T, Mink DR, Deniz Y, Lee
JH; TENOR Study Group. Demographic and clinical characteristics of
children and adolescents with severe or difficult-to-treat asthma. J
Allergy Clin Immunol 2007;119:1156-1163.
- Sheehan WJ, Phipatanakul W. Indoor allergen exposure and asthma
outcomes. Curr Opin Pediatr 2016;28:772-777.
- Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet
2014;383:1581-1592.
- Jartti
T,
Gern
JE. Role of viral infections in the development and exacerbation of
asthma in children.
J Allergy Clin
Immunol 2017;140:895-906.
- Zheng
XY, Xu YJ, Guan WJ,
Lin
LF. Regional, age and respiratory-secretion-specific prevalence of
respiratory viruses associated with asthma exacerbation: a literature
review. Arch Virol 2018;163:845-853.
- Wark PAB, Ramsahai JM, Pathinayake P, Malik B, Bartlett NW.
Respiratory viruses and asthma. Semin Respir Crit Care Med
2018;39:45-55.
- Hasegawa S, Hirano R, Hashimoto K, Haneda Y, Shirabe K, Ichiyama T.
Characteristics of
atopic children with pandemic H1N1 influenza viral infection: pandemic
H1N1 influenza reveals ’occult’ asthma of childhood. Pediatr Allergy
Immunol 2011;22:e119-e123.
- Athanasiou M, Lytras T, Spala G, Triantafyllou E, Gkolfinopoulou K,
Theocharopoulos G, Patrinos S, Danis K, Detsis M, Tsiodras S, Bonovas
S, Panagiotopolous T. Fatal cases associated with pandemic influenza A
(H1N1) reported in Greece. PLoS Curr 2010;2:RRN1194.
- Reichert T, Chowell G, Nishiura H, Christensen RA, McCullers JA. Does
glycosylation as a modifier of original antigenic sin explain the case
age distribution and unusual toxicity in pandemic novel H1N1
influenza? BMC Infect Dis 2010;10:5.
- Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J,
Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher
M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow
D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L. 2009
Pandemic Influenza A (H1N1) Virus Hospitalization Investigation Team.
Hospitalized patients with 2009 H1N1 influenza in the United States,
April-June 2009. N Engl J Med 2009;61:1935-1944.
- Okada S, Hasegawa S, Hasegawa H, Ainai A, Atsuta R, Ikemoto K, Sasaki
K, Toda S, Shirabe K, Takahara M, Harada S, Morishima T, Ichiyama T.
Analysis of bronchoalveolar lavage fluid in a mouse model of bronchial
asthma and H1N1 2009 infection. Cytokine 2013;63:194-200.
- Hasegawa S, Wakiguchi H, Okada S, Gui Kang Y, Fujii N, Hasegawa M,
Hasegawa H, Ainai A, Atsuta R, Shirabe K, Toda S, Wakabayashi-Takahara
M, Morishima T, Ichiyama T. Cytokine profile of bronchoalveolar lavage
fluid from a mouse model of bronchial asthma during seasonal H1N1
infection. Cytokine 2014;69:206-210.
- Fujimoto Y, Hasegawa S, Matsushige T, Wakiguchi H, Nakamura T,
Hasegawa H, Nakajima N, Ainai A, Oga A, Itoh H, Shirabe K, Toda S,
Atsuta R, Morishima T, Ohga S. Pulmonary inflammation and cytokine
dynamics of bronchoalveolar lavage fluid from a mouse model of
bronchial asthma during A(H1N1)pdm09 influenza infection. Sci Rep
2017;7:9128.
- Shim DH. Park YA, Kim MJ, Hong JY, Baek JY, Kim KW, Byun YH, Seong BL,
Ryu S, Song MK, Hong KJ, Na W, Song D, Park JH, Sohn MH, Lee JM.
Pandemic influenza virus, pH1N1, induces asthmatic symptoms via
activation of innate lymphoid cells. Pediatr Allergy Immunol
2015;26:780-788.
- McGovern TK, Robichaud A, Fereydoonzad L, Schuessler TF, Martin JG.
Evaluation of respiratory system mechanics in mice using the forced
oscillation technique. J Vis Exp 2013;75:e50172.
- Siddiqui S, Tsuchiya K, Risse PA, Bullimore SR, Benedetti A, Martin
JG. Site of allergic airway narrowing and the influence of exogenous
surfactant in the Brown Norway rat. PLoS One 2012;7:e29381.
- Kondo N, Nishimuta T, Nishima S, Morikawa A, Aihara Y, Akasaka T,
Akasawa A, Adachi Y, Arakawa H, Ikarashi T, Ikebe T, Inoue T, Iwata T,
Urisu A, Ebisawa M, Ohya Y, Okada K, Odajima H, Katsunuma T, Kameda M,
Kurihara K, Kohno Y, Sakamoto T, Shimojo N, Suehiro Y, Tokuyama K,
Nambu M, Hamasaki Y, Fujisawa T, Matsui T, Matsubara T, Mayumi M,
Mukoyama T, Mochizuki H, Yamaguchi K, Yoshihara S. Japanese pediatric
guidelines for the treatment and management of bronchial asthma 2008.
Pediatr Int. 2010;52:319-26.
- Postma DS, Kerstjens HA. Characteristics of airway hyperresponsiveness
in asthma and chronic obstructive pulmonary disease. Am J Respir Crit
Care Med 1998;158:S187-S192.
- Balfour-Lynn IM, Valman HB, Wellings R, Webster AD, Taylor GW,
Silverman M. Tumour necrosis factor-alpha and leukotriene E4
production in wheezy infants. Clin Exp Allergy 1994;24:121-126.
- Yasuda H, Suzuki T, Zayasu K, Ishizuka S, Kubo H, Sasaki T, Nishimura
H, Sekizawa K, Yamaya M. Inflammatory and bronchospastic factors in
asthma exacerbations caused by upper respiratory tract infections.
Tohoku J Exp Med 2005;207:109-118.
- Risse PA, Jo T, Suarez F, Hirota N, TOlloczko B, Ferraro P, Grutter P,
Martin JG. Interleukin-13 inhibits proliferation and enhances
contractility of human airway smooth muscle cells without change in
contractile phenotype. Am J Physiol Lung Cell Mol Physiol
2011;300:L958-L966.
- Gern JE, Dick EC, Lee WM, Murray S, Meyer K, Handzel ZT, Busse WW.
Rhinovirus enters but does not replicate inside monocytes and airway
macrophages. J Immunol 1996;156:621-627.
- Yamaya M. Virus infection-induced bronchial asthma exacerbation. Pulm
Med 2012;2012:834826.
- Rothlein R, Czajkowski M, O’Neill MM, Marlin SD, Mainolfi E, Merluzzi
VJ. Induction of intercellular adhesion molecule 1 on primary and
continuous cell lines by pro-inflammatory cytokines. Regulation by
pharmacologic agents and neutralizing antibodies. J Immunol
1988;141:1665-1669.
- Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R.
Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of
asthma. Science 1990;247:456-459.
- Malaviya
R,
Laskin
JD,
Laskin
DL. Anti-TNFα therapy in inflammatory lung diseases.
Pharmacol Ther.
2017;180:90-98.
- Anticevich SZ, Hughes JM, Black JL, Armour CL. Induction of human
airway hyperresponsiveness by tumour necrosis factor-α. Eur J
Pharmacol 1995;284:221-225.
- Choi IW, Sun K, Kim YS, Ko HM, Im SY, Kim JH,
You
HJ,
Lee
YC,
Lee
JH,
Park
YM,
Lee
HK. TNF-α induces the late-phase airway hyperresponsiveness and
airway inflammation through cytosolic phospholipase A2 activation. J
Allergy Clin Immunol 2005;116:537-543.
- Li BQ, Sun HC, Nie SN, Shao DB, Liu HM, Qian XM. Effect of
penehyclidine hydrochloride on patients with acute lung injury and its
mechanisms. Chin J Traumatol 2010;13:329-335.
- Reper P, Heijmans W. High-frequency percussive ventilation and initial
biomarker levels of lung injury in patients with minor burns after
smoke inhalation injury. Burns 2015;41:65-70.
- Singh S, Grover V, Christie L, Charles P, Kelleher P, Shah PL. A
comparative study of bronchoscopic microsample probe versus
bronchoalveolar lavage in patients with burns-related inhalational
injury, acute lung injury and chronic stable lung disease. Respiration
2015;89:19-26.
- Li T, Luo N, Du L, Zhou J, Zhang J, Gong L,
Jiang
N. Tumor necrosis factor-α plays an initiating role in extracorporeal
circulation-induced acute lung injury. Lung 2013;191:207-214.
- Neveu W, Allard JB, Dienz O, Wargo MJ, Ciliberto G, Whittaker LA,
Rincon
M. IL-6 is required for airway mucus production induced by inhaled
fungal allergens. J Immunol 2009;183:1732-8.
- Bozanich E, Gualano RC, Zosky GR, Larcombe AN, Turner DJ, Hantos Z,
Sly PD. Acute Influenza A infection induces bronchial
hyper-responsiveness in mice. Respir Physiol Neurobiol
2008;162:190-196.